Business Context and Reporting Period
This Form 8-K Current Report was filed by ORAGENICS INC on September 13, 2005. The report discloses a corporate governance event that occurred on September 9, 2005, regarding the appointment of principal officers.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on personnel changes and does not contain financial statements or performance data.
Material Changes
- Executive Appointment: Dr. Robert T. Zahradnik was named President and Chief Executive Officer (CEO) on September 9, 2005.
- Status Change: This appointment transitions Dr. Zahradnik from his previous status as acting President and CEO to a permanent role.
- Compensation: The employment arrangement remains unchanged, with Dr. Zahradnik receiving a monthly salary of $15,000, along with medical, dental, and retirement benefits consistent with company standards.
Guidance, Outlook, and Risks
The filing does not contain management commentary on future guidance, outlook, risks, contingencies, or unusual items. The document serves solely to announce the executive appointment and incorporates a press release as Exhibit 99.1.
Investor Verification Checklist
- Verify the permanent status of Dr. Robert T. Zahradnik as CEO and President.
- Confirm the compensation package details ($15,000/month plus benefits) as stated in the filing.
- Review the attached press release (Exhibit 99.1) for any additional strategic context not included in the 8-K text.